Drugs / Darbopoetin alpha
last change Jan 2013 re-read 2 minutes ago

Darbopoetin alpha

Developed for
liver disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01383460 Comparator Jul 2011 → Jan 2013 liver disorder Institute of Liver and Biliary Sciences, India Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Darbopoetin alpha “along with Darbopoetin alpha 100 mcg/ week (in prefilled syringe) for 4 weeks (total 4 doses)” NCT01383460